Thursday 11 March 2010 @ 12:07 am
Limerick BioPharma, Inc., a developer of innovative therapies that help cells pump unwanted or toxic substances away from vulnerable tissues, has announced positive results of a Phase 1a trial for its lead compound, LIM-0705, which has completed its first in man study.
Wednesday 10 March 2010 @ 9:46 pm
DEAR DR. GOTT: Recently, on a popular TV program, a person wascommenting on addictive drug usage. She was borrowing drugs fromother people and also taking what she was prescribed.
Wednesday 10 March 2010 @ 6:29 pm
A Nashville doctor whose medical license was once reinstated after a double murder conviction lost a court battle Wednesday to try to reopen his practice after a second run-in with the law.
Wednesday 10 March 2010 @ 5:42 pm
Chronic pain sufferers are waiting an average of six months to see a pain specialist in Australia's public health system.
Wednesday 10 March 2010 @ 5:16 pm
ATHENS TOWNSHIP — Two more individuals have been arrested on warrants obtained by the Bradford County Drug Task Force following the Investigation into illegal drug transactions in the area.
Wednesday 10 March 2010 @ 3:15 pm
MISSISSAUGA, ON, March 10 /PRNewswire-FirstCall/ - YM BioSciences Inc.
Allan Clear: Commission on Narcotic Drugs: Progress Towards a Pain Free World? (The Huffington Post)
Wednesday 10 March 2010 @ 1:45 pm
Although the Vienna International Center has upgraded its facilities (it now houses its meetings in an IKEA showroom), the opening session of the 53rd annual...
Allan Clear: Commission on Narcotic Drugs: Progress Towards a Pain Free World? (The Huffington Post)
Wednesday 10 March 2010 @ 1:45 pm
Although the Vienna International Center has upgraded its facilities (it now houses its meetings in an IKEA showroom), the opening session of the 53rd annual...
Wednesday 10 March 2010 @ 1:19 pm
BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced positive preliminary results from the first Phase I trial of fentanyl Lauriad®.
Wednesday 10 March 2010 @ 1:00 pm
YM BioSciences Inc. , today announced that it has closed its previously announced "registered direct" offering of 14,583,000 million units at an issue price of US $1.20 for gross proceeds of approximately US $17.5 million.


